Medical publication, MDedge on Friday reported that hydroxychloroquine (HCQ), the malaria drug, is currently the first-line therapy and Tocilizumab the second-line medication for people hospitalized with polymerase chain reaction-confirmed COVID-19 infection in the Yale New Haven Health System, which operates hospitals across Connecticut.from Moneycontrol Latest News https://www.moneycontrol.com/news/world-news/coronavirus-pandemic-|-several-us-hospitals-using-hcqtreatmentcovid-19-patients-report_13731141.html
0 Comments